Brand Name(s): Fosamax
CAS nº: 121268-17-5
(a-LEN-dro-nate)
About Alendronate
This site is dedicated exclusively to alendronate.
It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about alendronate, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.
This unique site will also offer you inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total alendronate experience!
Why is this medication prescribed?
Alendronate is in a class of medications used to strengthen the bone. A young bone is in a constant state of remodeling and is composed by cells called osteoblasts, whereby old bone is removed by cells called osteoclasts. Alendronate inhibits bone removal by the osteoclasts.
This medication is primarily used to treat osteoporosis (thinning of bone) in women after menopause. After menopause, there is an increased rate of bone loss (resorption). In these patients, alendronate has been shown to increase bone density while strengthening it at the same time, and decrease the rate of bone fractures.
Alendronate is also helpful in the treatment of Paget's disease of the bone. Paget's disease is characterized by a disorderly and accelerated remodeling of the bone, leading to bone weakness and pain.
Latest News
Amgen says denosumab improves bone vs Fosamax
Amgen Inc said on Monday a trial of its experimental osteoporosis drug, denosumab, showed it...
[more]Wal-Mart Expands Prescription Program for Generics
Wal-Mart says it will sell discounted 90-day supplies of up to 350 generic products as the third...
[more]Alendronate warning on atrial fibrillation
A drug commonly used to treat osteoporosis in women could increase atrial fibrillation (AF) risk...
[more]Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax®
Teva Pharmaceutical Industries Ltd. (Ticker: TEVA) announced the following decisions by two...
[more]Generic Fosamax Approved
The U.S. Food and Drug Administration approved the first generic versions of Fosamax (alendronate...
[more]Advertisement
Join Extrapounds.com and enjoy healthy weight loss!